Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.

Barr IG, Deng YM, Iannello P, Hurt AC, Komadina N.

Antiviral Res. 2008 Nov;80(2):200-5. doi: 10.1016/j.antiviral.2008.06.008. Epub 2008 Jul 9.

PMID:
18611414
2.

Changing selective pressure during antigenic changes in human influenza H3.

Blackburne BP, Hay AJ, Goldstein RA.

PLoS Pathog. 2008 May 2;4(5):e1000058. doi: 10.1371/journal.ppat.1000058.

3.

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC.

Nature. 2008 May 29;453(7195):667-71. doi: 10.1038/nature06890. Epub 2008 Apr 30.

4.

Human infection with highly pathogenic H5N1 influenza virus.

Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y.

Lancet. 2008 Apr 26;371(9622):1464-75. doi: 10.1016/S0140-6736(08)60627-3. Review.

PMID:
18440429
5.

Single-amino-acid mutation in the HA alters the recognition of H9N2 influenza virus by a monoclonal antibody.

Ping J, Li C, Deng G, Jiang Y, Tian G, Zhang S, Bu Z, Chen H.

Biochem Biophys Res Commun. 2008 Jun 20;371(1):168-71. doi: 10.1016/j.bbrc.2008.04.045. Epub 2008 Apr 18.

PMID:
18424263
6.

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Di Pucchio T, Chatterjee B, Smed-Sörensen A, Clayton S, Palazzo A, Montes M, Xue Y, Mellman I, Banchereau J, Connolly JE.

Nat Immunol. 2008 May;9(5):551-7. doi: 10.1038/ni.1602. Epub 2008 Mar 30.

7.

Update on avian influenza A (H5N1) virus infection in humans.

Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus., Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, Uyeki TM.

N Engl J Med. 2008 Jan 17;358(3):261-73. doi: 10.1056/NEJMra0707279. Review. No abstract available.

9.

Oseltamivir resistance during treatment of influenza A (H5N1) infection.

de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J.

N Engl J Med. 2005 Dec 22;353(25):2667-72.

10.

Oseltamivir resistance--disabling our influenza defenses.

Moscona A.

N Engl J Med. 2005 Dec 22;353(25):2633-6. No abstract available.

11.

Avian flu: isolation of drug-resistant H5N1 virus.

Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y.

Nature. 2005 Oct 20;437(7062):1108. Erratum in: Nature. 2005 Dec 8;438(7069):754.

PMID:
16228009
12.

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.

Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, Dernovoy D, Tatusova T, Bao Y, St George K, Taylor J, Lipman DJ, Fraser CM, Taubenberger JK, Salzberg SL.

Nature. 2005 Oct 20;437(7062):1162-6. Epub 2005 Oct 5.

PMID:
16208317
13.

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT, Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Webster RG, Peiris JS.

Nature. 2004 Jul 8;430(6996):209-13.

PMID:
15241415
14.

Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.

Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF.

Nat Med. 2002 Apr;8(4):373-8.

PMID:
11927943
15.

The role of the antibody response in influenza virus infection.

Gerhard W.

Curr Top Microbiol Immunol. 2001;260:171-90. Review. No abstract available.

PMID:
11443873
16.

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Skehel JJ, Wiley DC.

Annu Rev Biochem. 2000;69:531-69. Review.

PMID:
10966468
17.
18.

CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

Topham DJ, Tripp RA, Doherty PC.

J Immunol. 1997 Dec 1;159(11):5197-200.

PMID:
9548456
19.

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG.

Immunol Rev. 1997 Oct;159:105-17. Review.

PMID:
9416506

Supplemental Content

Support Center